Pousschine Cook Capital Management announces an investment in

NEW YORK, December 04, 2021 (GLOBE NEWSWIRE) – Pouschine Cook Capital Management, LLC, (“Pouschine Cook”) is pleased to announce its investment in Curexa Pharmacy (“Curexa” or the “Company”). Led by Co-Founder and CEO, Mark K. Taylor, R.Ph., Curexa is an API-connected 503A prep pharmacy partnering with direct-to-consumer telemedicine wellness brands growing to provide personalized pharmaceutical products. Curexa’s national reach and integrated technology enables the company to serve patients across the United States seeking medical treatment in the areas of men’s and women’s health, dermatology, mental health and general well-being.

Mark Taylor, CEO of Curexa, said: “We are extremely pleased to partner with Pouschine Cook as Curexa enters the next phase of its growth serving our patients and partners. Pouschine Cook brings decades of experience helping companies run by founders build much bigger businesses. We look forward to working with the team as we continue to expand our operations to meet the needs of the growing telemedicine industry. “

John Pouschine, Co-Founder of Pouschine Cook and President of Curexa, said, “Curexa fits perfectly with Pouschine Cook’s investment thesis as a growing healthcare and B2B company with a strong position. leader in its sector. The company is backed by a strong team with a demonstrated ability to meet the needs of its partners with personalized consulting service solutions. “

Robert Jenkins, Managing Director of Pouschine Cook and Member of the Board of Directors of Curexa, added that “with a strong capital base and reasonable leverage, Curexa will continue to exceed its already impressive growth trajectory by serving a broader range of customer partners and an expanding portfolio of product solutions for our patients. Brian Harrison, Director of Pouschine Cook and Member of the Board of Directors of Curexa, said that “with a significant transfer from management, we are closely aligned with our drive to accelerate investments in digital infrastructure and pharmaceuticals of Curexa to better integrate and serve our current and potential partners and patients. “

The institutional co-investors in the transaction were the Private Equity Solutions group of ORIX Corporation USA and Hexagon. Legal counsel to the buying group was McDermott Will & Emery LLP and senior credit facilities were provided by First Horizon Bank. Covington Associates has been the exclusive financial advisor to the company.

About Pousschine Cook Capital Management, LLC
Pouschine Cook is a New York-based private equity firm that invests in proven private lower-middle-market companies, with a focus on healthcare and specialty B2B products and services. The company was founded in 1999 by John Pouschine and Everett Cook with a focus on US-based companies that are leaders in their respective industries, have significant growth opportunities and are ready to benefit from the involvement. Pouschine Cook’s active and professional development expertise. Pouschine Cook specializes in offering direct co-investment opportunities for institutional investors and family offices alongside its own capital. For more information about Pouschine Cook, please visit www.pouschinecook.com.

About Curexa
Founded in 2003 in Egg Harbor Township, New Jersey, Curexa has grown from a retail pharmacy to a cutting edge compounding pharmacy supporting DTC telemedicine businesses by providing treatment and pharmacy expertise to its client partners across the states. -United. Curexa’s wide range of services include pre-launch support, custom formulations, API integration, packaging / branding, and pharmacy regulatory compliance. For more information about the Company, please visit www.curexa.com.


Source link